Ask most people when acne happens and they’ll say puberty. The evidence says otherwise. The landmark paper on adult acne, published in the Journal of the American Academy of Dermatology, opens by pointing out that acne is often wrongly thought to affect teenagers only.
This gap between perception and reality matters on two levels. Clinically, many adults don’t see themselves as acne patients, so they seek help late, often after years of self-treatment. Commercially, it leaves a population with spending power and high expectations looking for protocols and products designed for oily, reactive skin at 30, 40 or 50, not at 15.
The largest international survey so far is the ALL project, published in JAAD in 2024, which covered 50,000 people across 20 countries. It puts acne prevalence at 20.5%. Acne peaks between 16 and 24 (28.3%), but it still affects 19.3% of people between 25 and 39. Women are affected more often than men: 23.6% versus 17.5%.
Europe is no exception. Global Burden of Disease data put Western Europe at the top of the world for acne prevalence among under-25s. Age-standardised rates have also risen by about 0.55% a year for three decades. In a French survey of 3,305 women aged 25 to 40, validated by dermatologists, 41% had acne.
The gender gap widens with age. In self-reported data from the US study by Collier and Harper, 26.3% of women in their forties reported acne, compared with 12% of men. And 13% of women said their acne had got worse after adolescence.
Dermatologists now recognise adult female acne (AFA) as a distinct entity, defined as acne in women over 25. It takes three forms. Persistent acne continues from adolescence and accounts for 75–85% of cases. Late-onset acne appears for the first time in adulthood. Recurrent acne clears for years and then comes back.
Many women go through a second peak between their late thirties and early fifties. Around menopause, oestrogen levels drop while the ovaries keep producing androgens. Lesions cluster in the “U-zone” (jawline, chin, around the mouth). That skin is often already losing hydration, firmness and repair capacity. These patients want their acne treated without worsening dryness, sensitivity or signs of ageing. They have oily-skin problems and mature-skin needs at the same time.
The emotional cost is higher too. Acne hurts quality of life more in adults than in adolescents, and more in women than in men. Research presented at the EADV congress found that adult female acne in the U-zone scored lowest for perceived attractiveness.
The demand is there, and it is growing. Global Market Insights values the dermocosmetics market at around USD 39 billion in 2025 and forecasts more than USD 85 billion by 2035. The segment for acne-prone and sensitive skin alone is estimated at USD 5.5 billion in 2024, heading towards USD 9.8 billion by 2034. Teenagers and adults are both driving that growth. These are market research estimates, so read them as orders of magnitude.
Consumers are moving away from one-size-fits-all products towards tailored regimens. They want evidence-based actives in light, non-comedogenic textures. Yet pharmacies and mass retail still capture most of this spending. Aesthetic clinics and advanced beauty centres take only a small share, even though they are where adult patients go looking for a diagnosis and a plan.
Adults with oily or acne-prone skin aren’t one-off clients. They need an ongoing treatment pathway, and four things make the difference.
Spot them. Many adults don’t come in “for acne”. They come in about marks, enlarged pores, shine or scarring. A targeted assessment at consultation can uncover a need the patient hasn’t put into words.
Match the protocol to age. A 42-year-old woman’s acne-prone skin needs treatments that address sebum, comedones and inflammation while respecting the skin barrier. Those treatments also need to fit alongside the skin-quality and renewal treatments she may already be having.
Link clinic and home. In-clinic treatment delivers the result, and dedicated home care maintains it. A home routine prescribed by a professional builds loyalty and brings back spending that currently goes to the pharmacy.
Treat the aftermath. Scars and post-inflammatory hyperpigmentation are often what finally bring adults in. This is where aesthetic medicine and advanced aesthetics have their most specific expertise.
Know when to refer, too. Moderate-to-severe cases, or signs of an endocrine component such as hyperandrogenism or PCOS, belong with a dermatologist or endocrinologist. Referring at the right moment is part of what makes a practice credible.
Adult acne is common and on the rise, and it weighs more heavily on women, with a second peak around perimenopause. The market for products for oily and acne-prone skin is growing with it, but most of that spending still goes through pharmacies. The opportunity for practices is to close that gap. That means recognising the adult patient, offering a pathway suited to their age and supporting them at home with dedicated products. Practices that do this with clinical rigour will gain loyal patients rather than passing customers.
References
WiQo announces the first peer-reviewed study on the combined use of PRX PLUS and microneedling for multidimensional skin quality improvement. The pilot study showed significant improvements in texture, pigmentation, redness, pores, sebum levels and wrinkle severity, supporting a promising new protocol for professional skin-quality treatments.
The aesthetic medicine patient of 2026 looks nothing like the patient of five years ago. Younger, more prevention-focused, increasingly male, and often arriving through entirely new pathways — from weight loss clinics to perimenopause consultations. Understanding who is walking through your door, and why, is now as clinically relevant as knowing which treatment to offer them.
From the Palais des Congrès in Paris to the Grimaldi Forum in Monaco, the 2026 congress season delivered a single, unambiguous message: aesthetic medicine is no longer about correction. The field has entered a new biological era — one defined by tissue regeneration, cellular longevity, and proactive skin health. Here is what every practitioner needs to know coming out of IMCAS and AMWC 2026.
It’s a question we get all the time: “Can I buy PRX-T33 and do the treatment myself at home?” The short, clear, and most important
Official Channel
Follow our WhatsApp channel for clinical updates, PRX protocols and exclusive professional offers.
Follow on WhatsApp